March has come in like a lion for the folks at the Office of Research Integrity (ORI). The agency’s director, David Wright, stepped down late last month for reasons that even now remain unclear. And in what seems to be an unrelated development, ORI has managed to draw the ire of Sen. Charles Grassley, who … Continue reading Senator “unsatisfied” with ORI’s response on recovery of tainted grant money
A co-author of two papers claiming to have shown how to create stem cells simply and easily has requested their retraction, the Wall Street Journal is reporting:
Another busy week at Retraction Watch, including a ScienceOnline 2014 session Ivan facilitated on post-publication peer review. Here’s a selection of what was happening elsewhere on the web:
AAPS PharmSciTech, a journal of the American Association of Pharmaceutical Scientists, has retracted a 2013 paper by a group from India. The reason appears to be manipulated data, although the wording of the notice leaves that open to interpretation. The article, “Design and Formulation Technique of a Novel Drug Delivery System for Azithromycin and Its … Continue reading Pharmaceutical journal retracts antibiotics paper with dodgy data, with an unclear notice
Denis de Jesus Lima Guerra, a co-author on 11 chemistry papers that were retracted in 2011 for suspicions of fraud, has lost his position at the Federal University of Mato Grosso (UFMT). Bernardo Esteves, who was first to report the news, writes (courtesy Google Translate) that the dismissal was
Another busy week at Retraction Watch. Here’s a sampling of items about scientific publishing, research misconduct, and related issues from around the web:
One of the issues that comes up frequently when we’re moderating comments here on Retraction Watch is the distinction between “I think these images look strange” and “this researcher committed fraud.” That’s a pretty important distinction, because potentially actionable cases of libel live somewhere in between, probably closer to the latter — as Paul Brookes … Continue reading Where’s the line between scientific post-publication peer review critiques and libel?
Here at Retraction Watch, we judge retraction notices every day. We even have a category called “unhelpful retraction notices.” But we haven’t systematically analyzed those notices, so lucky for us, a group of academics at Vanderbilt decided to. In a new paper published in a special issue of Publications — an issue whose editor, Grant … Continue reading A rating system for retractions? How various journals stack up
There were lots of pieces about scientific misconduct, publishing, and related issues posted around the web this week, so without further ado:
Last week, we reported on the retraction of a paper by Benjamin Jacob Hayempour, a researcher who had threatened to sue us last month for even reporting on another of his retractions. The journal, Cureus, told us at the time that the retraction — in which the article disappeared, without a notice — didn’t have … Continue reading Journal reveals real reason for retraction of paper by author who threatened to sue Retraction Watch